← Browse by Condition
Medical Condition

ards

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for ards sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — ards Clinical Trials

How many clinical trials are currently recruiting for ards?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for ards, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ards?
ards research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ards clinical trial?
Eligibility criteria for ards trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
University Hospital, Angers 1 trial
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1 trial
Hong Kong University 1 trial
PPD Development, LP 1 trial
University Hospitals, Leicester 1 trial

Recruiting Clinical Trials

NCT05578742
Recruiting
V/Q Matching Variations With PEEP in ARDS According to Compliance-based Phenotypes (France)
Enrollment
50 pts
Location
France
Sponsor
University Hospital, Angers
View Trial →
NCT05591924
Recruiting
Early Severe Illness TrAnslational BioLogy InformaticS in Humans
Enrollment
1,000 pts
Location
Canada
Sponsor
London Health Sciences Centre ...
View Trial →
NCT07161271
Recruiting
Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure
Enrollment
59 pts
Location
Hong Kong
Sponsor
Hong Kong University
View Trial →
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT06179771
Recruiting
Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support.
Enrollment
40 pts
Location
United Kingdom
Sponsor
University Hospitals, Leiceste...
View Trial →

Related Conditions

inflammation (2) sepsis (1) critical illness (1) neurocognitive dysfunction (1) shock septic (1) ventilator associated pneumonia (1) immune suppression (1) sirs (1) respiratory failure (1) icu (1) asthma diagnosis (1) acute respiratory distress syndrome ards (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology